Evidence map›Paper›PMID 33768230›Full record

ArticleEuropean heart journal2021

Stress-associated neurobiological activity associates with the risk for and timing of subsequent Takotsubo syndrome.

Azar Radfar, Shady Abohashem, Michael T Osborne, Ying Wang, Tawseef Dar, Malek Z O Hassan, Ahmed Ghoneem, Nicki Naddaf, Tomas Patrich, Taimur Abbasi and 9 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in European heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05793008 narecruitingnot on this mapstarted 2023, after this paper: background citation

Characterization of priMary And sEcondary STress Related takOtsubo: the MAESTRO Pilot Study

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2023 to 2026Enrolled60ConditionsTakotsubo Cardiomyopathy, Sepsis-induced CardiomyopathyArmsPositron Emission Tomography (PET) analysis, Blood samples collection, Clinical follow up visit
NCT06429293 narecruitingnot on this mapstarted 2023, after this paper: background citation

Impact of Cognitive Behavioral Therapy on Neural, Inflammatory, & Autonomic Markers in a Sample With PTSD and Cardiovascular Risk: Protocol for a Pilot Randomized Controlled Trial

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2026Enrolled30ConditionsPosttraumatic Stress DisorderArmsCognitive processing therapy
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. The relation between stress-related neural activity assessed by brainEuropean journal of nuclear medicine and molecular imaging · 2025
    Pooled it
  2. The role of central autonomic nervous system dysfunction in Takotsubo syndrome: a systematic review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2022
    Pooled it
  3. Review
  4. Cardiovascular imaging with total-body PET.The British journal of radiology · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Observational
  10. Article
  11. Incidence of ischemic stroke in Takotsubo cardiomyopathy patients: a systematic review and meta-analysis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Stress and Acute Coronary Syndrome.Cardiology research · 2025
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Azar RadfarCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.
Shady AbohashemCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.ORCID 0000-0002-5033-8881
Michael T OsborneCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.ORCID 0000-0003-1001-1718
Ying WangCardiovascular Imaging Research Center, Boston, MA, USA.ORCID 0000-0002-5391-9614
Tawseef DarCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.
Malek Z O HassanCardiovascular Imaging Research Center, Boston, MA, USA.
Ahmed GhoneemCardiovascular Imaging Research Center, Boston, MA, USA.ORCID 0000-0002-9089-599X
Nicki NaddafCardiovascular Imaging Research Center, Boston, MA, USA.ORCID 0000-0001-9651-4070
Tomas PatrichCardiovascular Imaging Research Center, Boston, MA, USA.
Taimur AbbasiCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.ORCID 0000-0003-1392-9540
Hadil ZureigatCardiovascular Imaging Research Center, Boston, MA, USA.
James JafferCardiovascular Imaging Research Center, Boston, MA, USA.
Parastou GhaziCardiovascular Imaging Research Center, Boston, MA, USA.ORCID 0000-0002-3833-0385
James A ScottDepartment of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Lisa M ShinDepartment of Psychology, Tufts University, Medford, MA, USA.
Roger K PitmanDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Tomas G NeilanCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.
Malissa J WoodCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.
Ahmed TawakolCardiology Division, Massachusetts General Hospital and Harvard Medical School, MA, USA.ORCID 0000-0002-9211-5483
Harvard University · USCardiovascular Research Associates · USTufts University · US

Funding

Translational imaging and nanomedicine in inflammatory atherosclerosisP01HL131478 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Mandy Maria Theresia van Leent · 2017 to 2026
$24.3M
Institutional Career Development CoreKL2TR002542 · NCATS · HARVARD MEDICAL SCHOOL · PI BREDELLA, MIRIAM ANTOINETTE, RUTKOVE, SEWARD B. · 2018 to 2022
$8.7M
Cardiac MR and CT ResearchT32HL076136 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G · 2004 to 2019
$4.9M
Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIVR01HL149516 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LO, JANET, TAWAKOL, AHMED A · 2020 to 2024
$3.9M
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionR01HL152957 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER W HUNT, Priscilla Y. Hsue · 2020 to 2026
$3.7M
Novel PET/CT and Treatment Strategies to reduce PTS following DVTR01HL137913 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI JAFFER, FAROUC AMIN, TAWAKOL, AHMED A · 2017 to 2020
$3.3M
STOP-CA: Statins to prevent Cardiotoxicity from AnthracyclinesR01HL130539 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G, SCHERRER-CROSBIE, MARIELLE · 2016 to 2020
$3.2M
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)R33HL141047 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y., LU, MICHAEL TSE-YIN · 2019 to 2022
$2.9M
Mechanisms of Cardiac Dysfunction in HIV and the Effect of StatinsR01HL137562 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G, ZANNI, MARKELLA V. · 2017 to 2020
$2.7M
Cardiovascular Imaging in Ischemic Heart DiseaseK24HL113128 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2012 to 2020
$1.1M
The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease: A Multi-System PET/MRI StudyK23HL151909 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI OSBORNE, MICHAEL THOMAS · 2021 to 2025
$997k
Cardiovascular Diseases among Patients with Cancer and Patients living with HIVK24HL150238 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Tomas G Neilan · 2020 to 2026
$883k
NCATS NIH HHS KL2 TR002542NHLBI NIH HHS K23 HL151909NHLBI NIH HHS K24 HL113128NHLBI NIH HHS K24 HL150238NHLBI NIH HHS P01 HL131478NHLBI NIH HHS R01 HL130539NHLBI NIH HHS R01 HL137562NHLBI NIH HHS R01 HL137913NHLBI NIH HHS R01 HL149516NHLBI NIH HHS R01 HL152957NHLBI NIH HHS R33 HL141047NHLBI NIH HHS T32 HL076136NIAMS NIH HHS R56 AR077187
6 · The paper itself

Abstract

aimsActivity in the amygdala, a brain centre involved in the perception of and response to stressors, associates with: (i) heightened sympathetic nervous system and inflammatory output and (ii) risk of cardiovascular disease. We hypothesized that the amygdalar activity (AmygA) ratio is heightened among individuals who develop Takotsubo syndrome (TTS), a heart failure syndrome often triggered by acute stress. We tested the hypotheses that (i) heightened AmygA precedes development of TTS and (ii) those with the highest AmygA develop the syndrome earliest. METHODS AND

resultsIndividuals (N=104, median age 67.5 years, 72% female, 86% with malignancy) who underwent clinical 18 F-FDG-PET/CT imaging were retrospectively identified: 41 who subsequently developed TTS and 63 matched controls (median follow-up 2.5 years after imaging). AmygA was measured using validated methods. Individuals with (vs. without) subsequent TTS had higher baseline AmygA (P=0.038) after adjusting for TTS risk factors. Further, AmygA associated with the risk for subsequent TTS after adjustment for risk factors [standardized hazard ratio (95% confidence interval): 1.643 (1.189, 2.270), P=0.003]. Among the subset of individuals who developed TTS, those with the highest AmygA (>mean + 1 SD) developed TTS ∼2 years earlier after imaging vs. those with lower AmygA (P=0.028).

conclusionHigher AmygA associates with an increased risk for TTS among a retrospective population with a high rate of malignancy. This heightened neurobiological activity is present years before the onset of TTS and may impact the timing of the syndrome. Accordingly, heightened stress-associated neural activity may represent a therapeutic target to reduce stress-related diseases, including TTS.

Indexed as

Takotsubo CardiomyopathyAgedAmygdalaFemaleFluorodeoxyglucose F18HumansMalePositron Emission Tomography Computed TomographyRetrospective StudiesFluorodeoxyglucose F1818F-FDG-PET/CTAmygdalar activityStressTakotsubo syndrome

Identifiers

PMID33768230
PMCPMC8121551
OpenAlexW3138167890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.